Pharmafile Logo
Pharmafocus logo
Advanced Search
genentech_web

Genentech to axe 223 staff from San Francisco HQ

August 17, 2018
Manufacturing and Production, Medical Communications Genentech, Roche, layoffs, pharma

Roche subsidiary Genentech has announced plans to axe 223 employees from its headquarters in San Francisco, California, beginning on 31 …

News

CCP fire provincial official and investigate drug regulator in response to Changsheng vaccine scandal

August 17, 2018
Medical Communications China, Vaccine, changsheng, drug safety, regulation

The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …

News

GSK announces closure of Sligo, Ireland facilties

August 17, 2018
Medical Communications GSK, GlaxoSmithKilne, Ireland, Sligo, closure, manfuacturing

British multinational GlaxoSmithKline has announced the closure of its manufacturing facilities in Sligo, Ireland. The company is set to wind …

News
blood-75301_640

“Triple pill” blood pressure combo proves more effective, safe than standard care

August 16, 2018
Research and Development blood pressure, heart attack, heart disease, pharma, triple pill

A “triple pill” combining three established and effective drugs at low dosage levels could prove much more effective in treating …

News
6813384933_1fb31d73fb_z

Ibalisumab effective in in treating multidrug resistant HIV

August 16, 2018
Research and Development AIDS, HIV, multidrug resistance, phase 3

The monoclonal antibody Ibalizumab has shown significant antiviral activity against multidrug resistant HIV infections, according to the results of a …

News
1280px-old_surgical_hospital_drummond_street

Regenerative process could be restored in liver after severe injuries, study shows

August 16, 2018
Research and Development Edinburgh University, liver, mice, research, transplants

Scientists at the University of Edinburgh were able to restore a regenerative response that prevented the need for a liver …

News

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018
Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

News
dubai

Indian biotech owner detained in Dubai over £550m fraud allegations

August 16, 2018
Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …

News

Realm Therapeutics shares halved after failure of Phase 2 study

August 15, 2018
Research and Development London, Shares, atopic dermatitis, phase 2, stock market

Shares in the London-listed Realm Therapeutics plummeted on Monday after the company reported that a Phase II study of the …

News

Janssen and ViiV’s monthly injectable HIV combo proves non-inferior to daily standard of care

August 15, 2018
Research and Development HIV, Janssen, ViiV Healthcare, pharma

Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, …

News

Rotavirus vaccine shown to reduce risk of death by 34% in Malawi

August 15, 2018
Research and Development Rotavirus, diarrhoea, malawi, vaccination program, vaccines

A rotavirus vaccine was successful in reducing diarrhoea related deaths in infants in Malawi by 34%, a study led by …

News

New York sues Purdue Pharma over opioid crisis

August 15, 2018
Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state

New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …

News
gilead-sciences

Gilead CMO announces departure alongside two new exec appointments

August 15, 2018
Medical Communications, Research and Development Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …

News
charles_hugh_jones

Pfizer CMO Charles Hugh-Jones set to join Allergan in return to New Jersey

August 14, 2018

The Dublin headquartered multinational, Allergan has appointed Pfizer CMO Charles Hugh-Jones as their new Senior Vice President and Chief Medical …

Appointment

Fentanyl execution gets go-ahead in federal court

August 14, 2018
Manufacturing and Production Nebraska, execution, fatalities, fentanyl, valium

The first execution in the United States using the powerful opioid fentanyl, is set to take place in Nebraska on …

News
biogen_austria_238

NICE rejects Biogen’s spinal muscular dystrophy drug Spinraza after long delay

August 14, 2018
Manufacturing and Production, Sales and Marketing Biogen, NICE, Spinraza, UK, pharma, spinal muscular dystrophy

UK watchdog NICE has rejected Biogen’s spinal muscular dystrophy drug Spinraza (nusinersen) over cost concerns, denying patients the only available …

News
staphylococcus_aureus_50000x_usda_ars_emu

Researchers design new class of drugs to counter cardiovascular disease

August 14, 2018
Manufacturing and Production TMAO, cardiovascular, gut microbe, heart attack, research

Cleveland Clinic researchers have designed a potential new class of drugs that may reduce the risk of cardiovascular disease by …

News
cancer-vs-alzheimer-1080x810

“Radical radiotherapy” cuts required treatments from 37 to 5

August 14, 2018
Manufacturing and Production Cancer, oncology, pharma, radiotherapy

Researchers at Queen’s University Belfast have been trialling a new form of “radical radiotherapy” which can be delivered in just …

News
3922609891_dced293244_z

Rare lung cancer drug approved in Scotland

August 14, 2018
Manufacturing and Production Cancer, SMC, Scotland, Scottish Medicines Consortium, approval, lung cancer

The Scottish Medicines Consortium has approved Roche’s cancer drug alectinib for the treatment of patients with untreated advanced non-small-cell lung …

News
nawal_ouzren_-_sensorion_alt

Working Life: Nawal Ouzren, CEO of Sensorion

August 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Sensorion, Working Life, feature, pharma

Pharmafocus caught up with Sensorion CEO Nawal Ouzren to take a look at her path throughout her career and get …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026